- Home
- ATRO vs TXG Comparison
ATRO vs TXG Comparison
Compare ATRO & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRO
- TXG
- Stock Information
- Founded
- ATRO 1968
- TXG 2012
- Country
- ATRO United States
- TXG United States
- Employees
- ATRO N/A
- TXG N/A
- Industry
- ATRO Military/Government/Technical
- TXG Biotechnology: Laboratory Analytical Instruments
- Sector
- ATRO Industrials
- TXG Industrials
- Exchange
- ATRO Nasdaq
- TXG Nasdaq
- Market Cap
- ATRO 1.7B
- TXG 1.6B
- IPO Year
- ATRO N/A
- TXG 2019
- Fundamental
- Price
- ATRO $52.51
- TXG $15.93
- Analyst Decision
- ATRO Strong Buy
- TXG Buy
- Analyst Count
- ATRO 1
- TXG 13
- Target Price
- ATRO $58.00
- TXG $14.50
- AVG Volume (30 Days)
- ATRO 640.4K
- TXG 3.3M
- Earning Date
- ATRO 11-04-2025
- TXG 11-06-2025
- Dividend Yield
- ATRO N/A
- TXG N/A
- EPS Growth
- ATRO N/A
- TXG N/A
- EPS
- ATRO N/A
- TXG N/A
- Revenue
- ATRO $830,601,000.00
- TXG $641,814,000.00
- Revenue This Year
- ATRO $9.20
- TXG $2.07
- Revenue Next Year
- ATRO $6.39
- TXG N/A
- P/E Ratio
- ATRO N/A
- TXG N/A
- Revenue Growth
- ATRO 6.19
- TXG 1.92
- 52 Week Low
- ATRO $14.13
- TXG $6.78
- 52 Week High
- ATRO $52.58
- TXG $17.70
- Technical
- Relative Strength Index (RSI)
- ATRO 70.27
- TXG 62.12
- Support Level
- ATRO $46.63
- TXG $12.80
- Resistance Level
- ATRO $48.74
- TXG $17.70
- Average True Range (ATR)
- ATRO 2.35
- TXG 0.97
- MACD
- ATRO -0.02
- TXG 0.30
- Stochastic Oscillator
- ATRO 97.29
- TXG 66.79
About ATRO Astronics Corporation
Astronics Corp supplies products to the aerospace, defense, and electronics industries. The company has two reportable segments namely Aerospace and Test Systems. The aerospace segment serves three primary markets: military, commercial transport, and General Aviation. The Test Systems segment serves the aerospace, defense, and semiconductor markets. The company generates a majority of its revenue from the Aerospace segment. Geographically, it generates a majority of its revenue from the United States.
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).